Antonio M. Jimenez Jimenez, M.D.
- Assistant Professor
- Attending Physician
Dr. Jimenez Jimenez’s area of clinical and research interest is the use of hematopoietic stem cell transplantation (HSCT) and cell therapy for management of high-risk acute leukemias (myeloid and lymphoid) and myelodysplastic syndromes/ myeloproliferative neoplasms ( MDS/MPN). Additionally, he is interested in assessing genetic factors that predict post-transplant relapse and strategies to minimize or manage this complication. As a faculty member at Sylvester Cancer Center, Dr. Jimenez Jimenez is very interested in evaluating transplant outcomes for AML/ALL/MDS patients at their institution but most importantly develop strategies to improve clinical outcomes and help transplant recipients to achieve durable remissions. During his HSCT fellowship training, Dr. Jimenez Jimenez focused on developing a combined genetic prognostic model to predict clinical outcomes in acute myeloid leukemia patients receiving consolidation with allogeneic HSCT. Findings from this project led to peer-reviewed publications and presentations and created a risk-stratification foundation to conduct and design future interventional trials in high-risk AML patients